Task: Answer the multiple-choice question.
Question: Which drug has a -10.234% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCCNC(=O)C(Cc1cccc(C#N)c1)NC(=O)c1cccc([N+](=O)[O-])c1
b) Cn1cccc1/C=C1\SC(=S)N(NC(=O)c2ccccc2O)C1=O
Answer: a. CCCNC(=O)C(Cc1cccc(C#N)c1)NC(=O)c1cccc([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)C(Cc1cccc(C#N)c1)NC(=O)c1cccc([N+](=O)[O-])c1
CCCNC(=O)C(Cc1cccc(C#N)c1)NC(=O)c1cccc([N+](=O)[O-])c1
N-[3-(3-cyanophenyl)-1-oxo-1-(propylamino)propan-2-yl]-3-nitrobenzamide